Anavex Life Sciences Corp.
Organization details
- Legal name
- Anavex Life Sciences Corp.
- Former names
- Thrifty Printing Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- AVXL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001314052
- EIN
- 98-0608404
Board of directors
-
Adrian Senderowicz · DirectorSince 2026
-
Athanasios Skarpelos · DirectorSince 2023
-
Axel Paeger · DirectorSince 2026
-
Christopher U. Missling · Director · President and CEOSince 2023
-
Claus Vander Velden · DirectorSince 2023
-
Gautam Patel · DirectorSince 2026
-
Jiong Ma · DirectorSince 2023
-
Peter D.o. Donhauser · DirectorSince 2023
-
Steffen Thomas · DirectorSince 2023
-
Terrie Kellmeyer · Director · President and CEOSince 2026
Chief executives
Director election results
Annual meeting of September 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
72.1%
-
77.8%
Board connections
3 of this board's directors also sit on 5 other boards. 2 are in the same sector.
-
Amneal Pharmaceuticals Inc. Same sectorvia Gautam Patel
- via Jiong Ma
-
Puma Biotechnology Inc Same sectorvia Adrian Senderowicz
- via Jiong Ma
- via Gautam Patel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2025 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +187,500 | $5.04 | $945,000 |
| Sep 11, 2025 | Christopher U. Missling Director, Officer (President and CEO) | Shares withheld for tax | −145,048 | $9.58 | $1,389,560 |
| Jun 5, 2025 | Steffen Thomas Director | Option exercise | +50,000 | $1.76 | $88,000 |
| Jun 5, 2025 | Steffen Thomas Director | Shares withheld for tax | −11,349 | $7.75 | $87,955 |
| Mar 24, 2025 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +500,000 | $0.92 | $460,000 |
| Mar 24, 2025 | Christopher U. Missling Director, Officer (President and CEO) | Shares withheld for tax | −282,497 | $9.63 | $2,720,446 |
| Jun 14, 2024 | Peter D.o. Donhauser Director | Open-market purchase | +2,835 | $3.64 | $10,319 |
| May 15, 2024 | Steffen Thomas Director | Open-market purchase | +5,000 | $4.52 | $22,600 |
| Mar 28, 2024 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +73,380 | $1.32 | $96,862 |
| Mar 28, 2024 | Christopher U. Missling Director, Officer (President and CEO) | Open-market sale | −73,380 | $5.11 | $374,972 |
| Jun 29, 2023 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +232,000 | $1.60 | $371,200 |
| Jun 28, 2023 | Christopher U. Missling Director, Officer (President and CEO) | Option exercise | +268,000 | $1.60 | $428,800 |
| Jun 28, 2023 | Christopher U. Missling Director, Officer (President and CEO) | Open-market sale | −268,000 | $7.98 | $2,138,640 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Anavex Life Sciences Corp.
Who is the CEO of Anavex Life Sciences Corp.?
Christopher U. Missling is Anavex Life Sciences Corp.'s President and CEO.
How many directors are on Anavex Life Sciences Corp.'s board?
Anavex Life Sciences Corp.'s board has 10 directors: Adrian Senderowicz, Athanasios Skarpelos, Axel Paeger, Christopher U. Missling, Claus Vander Velden, Gautam Patel, Jiong Ma, Peter D.o. Donhauser, Steffen Thomas and Terrie Kellmeyer.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="anavex-life-sciences-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.